Research progress in Clostridium perfringens toxin vaccines
Author:
Affiliation:

1.Key Laboratory of Ministry of Education for Conservation and Utilization of Special Biological Resources in Western China, Ningxia University, Yinchuan 750021, China;2.School of Life Science, Ningxia University, Yinchuan 750021, China

Clc Number:

R186  R378

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Comments
    Abstract:

    Clostridium perfringens is an important foodborne pathogen that causes intestinal infections and tissue necrosis in both human and animals. A variety of exotoxins it produces are lethal. The increasing demand for ratio-nal use of antimicrobial agents and healthy farming make the implementation of vaccination critically important. However, traditional Clostridium perfringens exotoxin vaccines may have problems such as inconsistent efficacy, residual toxins and formaldehyde, raising concerns about the safety of these vaccines. This article systematically introduces the latest research progress in traditional toxoid vaccine, genetically engineered recombinant vaccines, and epitope peptide vaccines designed based on reverse vaccinology and immunoinformatics for Clostridium perfringens, providing new ideas for the development and preparation of effective and safe novel Clostridium perfringens toxin vaccines.

    Reference
    Related
Get Citation

王东,张思雨,丁雅文,等.产气荚膜梭菌毒素疫苗研究进展[J].中国感染控制杂志英文版,2024,23(7):910-917. DOI:10.12138/j. issn.1671-9638.20245387.
Dong WANG, Si-yu ZHANG, Ya-wen DING, et al. Research progress in Clostridium perfringens toxin vaccines[J]. Chin J Infect Control, 2024,23(7):910-917. DOI:10.12138/j. issn.1671-9638.20245387.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:December 26,2023
  • Revised:
  • Adopted:
  • Online: August 13,2024
  • Published: